Table 1 Confidence in managing CKD and DM in different age groups
Confidence | 0-34 | 35-54 | 55+ | p | |||
|---|---|---|---|---|---|---|---|
| Â | N | % | N | % | N | % | Â |
Managing hypertension | 23 | 100.0% | 75 | 80.6% | 29 | 93.5% | 0.02 |
Managing hypertension in patients with CKD | 16 | 69.6% | 47 | 50.0% | 24 | 77.4% | 0.01 |
Managing hypertension in patients with CKD with DM | 15 | 65.2% | 52 | 55.3% | 23 | 74.2% | 0.16 |
Achieving lowered blood pressure in patients with CKD | 17 | 73.9% | 37 | 39.4% | 19 | 61.3% | 0.00 |
Interpreting eGFR to stage CKD | 20 | 87.0% | 58 | 61.7% | 25 | 80.6% | 0.02 |
Monitoring eGFR in patients with CKD | 20 | 87.0% | 58 | 61.7% | 24 | 77.4% | 0.03 |
Monitoring eGFR in CKD patient with DM | 16 | 69.6% | 48 | 51.1% | 25 | 80.6% | 0.01 |
Using urine protein results to manage DM | 15 | 65.2% | 37 | 39.4% | 18 | 58.1% | 0.03 |
Using urine protein results to manage CKD | 12 | 52.2% | 35 | 37.2% | 15 | 48.4% | 0.31 |
Using ACE inhibitors and/or ARB | 22 | 95.7% | 71 | 75.5% | 26 | 83.9% | 0.08 |
Using ACE inhibitors and/or ARB in patients with CKD | 19 | 82.6% | 55 | 58.5% | 24 | 77.4% | 0.03 |
Using other anti-hypertensives in patients with CKD | 18 | 78.3% | 54 | 57.4% | 23 | 74.2% | 0.08 |
Adding a loop diuretic drug (e.g. furosemide) to patients with CKD already on maximum dose of an ACE I and/or ARB | 7 | 30.4% | 26 | 27.7% | 16 | 51.6% | 0.05 |
Using referral guidelines to refer appropriate patients with DM to secondary care | 12 | 52.2% | 51 | 54.3% | 26 | 83.9% | 0.01 |
Using referral guidelines to refer appropriate patients with CKD to secondary care | 13 | 56.5% | 43 | 45.7% | 25 | 80.6% | 0.00 |
Overall management of patients with DM | 15 | 65.2% | 54 | 57.4% | 26 | 83.9% | 0.03 |
Overall management of patients with CKD | 9 | 39.1% | 44 | 46.8% | 22 | 71.0% | 0.03 |